Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)
| 1.76 Delayed Data As of 4:00pm ET |  -0.12 / -6.38%Today’s Change | 1.63 Today|||52-Week Range 41.28 | -84.62% Year-to-Date |
Latest TNXP News | Press Releases
No recent news for Tonix Pharmaceuticals Holding Corp.
Today’s Trading
| Previous close | 1.88 |
| Today’s open | 1.80 |
| Day’s range | 1.74 - 1.83 |
| Volume | 110,685 |
| Average volume (3 months) | 4,460,216 |
| Market cap | $35.2M |
Data as of 4:00pm ET, 06/27/2022
Growth & Valuation
| Earnings growth (last year) | +53.55% |
| Earnings growth (this year) | +26.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGLSRegulus Therapeutics... | -0.03 | -13.98% |
| ---- | ||
| ERYPErytech Pharma SA | +0.01 | +0.88% |
| ---- |
Data as of 5:55pm ET, 06/27/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$1.45 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$92.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Chatham, New Jersey |
Forecasts
